Correlation Between Beta Drugs and Dhunseri Investments

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Beta Drugs and Dhunseri Investments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and Dhunseri Investments into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beta Drugs and Dhunseri Investments Limited, you can compare the effects of market volatilities on Beta Drugs and Dhunseri Investments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of Dhunseri Investments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and Dhunseri Investments.

Diversification Opportunities for Beta Drugs and Dhunseri Investments

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Beta and Dhunseri is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and Dhunseri Investments Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dhunseri Investments and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with Dhunseri Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dhunseri Investments has no effect on the direction of Beta Drugs i.e., Beta Drugs and Dhunseri Investments go up and down completely randomly.

Pair Corralation between Beta Drugs and Dhunseri Investments

Assuming the 90 days trading horizon Beta Drugs is expected to generate 1.05 times more return on investment than Dhunseri Investments. However, Beta Drugs is 1.05 times more volatile than Dhunseri Investments Limited. It trades about -0.07 of its potential returns per unit of risk. Dhunseri Investments Limited is currently generating about -0.19 per unit of risk. If you would invest  201,670  in Beta Drugs on October 23, 2024 and sell it today you would lose (11,170) from holding Beta Drugs or give up 5.54% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Beta Drugs  vs.  Dhunseri Investments Limited

 Performance 
       Timeline  
Beta Drugs 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.
Dhunseri Investments 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dhunseri Investments Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Beta Drugs and Dhunseri Investments Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Beta Drugs and Dhunseri Investments

The main advantage of trading using opposite Beta Drugs and Dhunseri Investments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, Dhunseri Investments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dhunseri Investments will offset losses from the drop in Dhunseri Investments' long position.
The idea behind Beta Drugs and Dhunseri Investments Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing